Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 1.79%.

  • bioAffinity Technologies' Return on Capital Employed rose 2400.0% to 1.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.79%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 2.1% for FY2024, which is 11000.0% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Return on Capital Employed stood at 1.79%, which was up 2400.0% from 3.93% recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Return on Capital Employed peaked at 0.33% during Q4 2022, and registered a low of 3.93% during Q2 2025.
  • Its 4-year average for Return on Capital Employed is 1.72%, with a median of 1.52% in 2024.
  • Over the last 5 years, bioAffinity Technologies' Return on Capital Employed had its largest YoY gain of 2400bps in 2025, and its largest YoY loss of -23700bps in 2025.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Return on Capital Employed stood at 0.33% in 2022, then crashed by -242bps to 1.15% in 2023, then crashed by -128bps to 2.61% in 2024, then skyrocketed by 31bps to 1.79% in 2025.
  • Its Return on Capital Employed stands at 1.79% for Q3 2025, versus 3.93% for Q2 2025 and 3.68% for Q1 2025.